Edoxaban Tosylate Tablet, Film Coated
NDC Package 66003-202-01
Package Information
Edoxaban Tosylate tablets is edoxaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation). This formulation utilizes a tablet, film coated delivery system. Marketed by Daiichi Sankyo Europe Gmbh, this product is identified by NDC 66003-202.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 66003 - Daiichi Sankyo Europe Gmbh
- 66003-202 -
- 66003-202-01 - 119000 TABLET, FILM COATED in 1 DRUM
- 66003-202 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 66003-202-01 identifies a specific commercial package of 119000 tablet, film coated in 1 drum of Edoxaban Tosylate (UNFINISHED drug), drug for further processing labeled by Daiichi Sankyo Europe Gmbh. This tablet, film coated is formulated for use and contains edoxaban tosylate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Daiichi Sankyo Europe Gmbh on January 12, 2015. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Edoxaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation). It is also used to treat certain blood clots (such as in deep vein thrombosis-DVT or pulmonary embolus-PE). Edoxaban is an anticoagulant that works by blocking certain clotting proteins in your blood.
How is this Daiichi Sankyo Europe Gmbh product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 66003020201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.